Track Record 1998

1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 & 2019



Our covered positions for the Newsletter Portfolio are below.
70% have been for GAINS of 50% or GREATER.

RIVENDELL WINERY OF N.Y. Closed on 1/22/98 at $1.75 for a 143% GAIN

VICON INDUSTRIES Closed on 1/16/98 at $9.50 for a 61% GAIN

CYDSA Closed on 1/30/98 at $3.58 for a 40% GAIN

ENHANCED SERVICES Closed on 3/17/98 at $7.62 for a 96% GAIN

MANHATTAN CARD Closed on 3/24/98 at 34¢ for a 15% LOSS

FOUNDER, LTD. Closed on 3/24/98 at 72¢ for a 6% GAIN

AMERICAN PAGING Closed on 3/31/98 at $2.50 for a 25% GAIN

AUTOINFO, INC. Closed on 5/6/98 at 38¢ for a 81% LOSS

SEVENTH GENERATION Closed on 5/7/98 at $1.44 for a 206% GAIN

INTERJETNET CORPORATION Closed on 7/2/98 at $9.37 for a 167% GAIN

GLOBALINK, INC. Closed on 7/6/98 at $5.25 for a 147% GAIN

AMERICAN CRAFT BREWING Closed on 7/7/98 at 31¢ for a 82% LOSS

GEOTEK COMMUNICATIONS Closed on 7/13/98 at 8¢ for a 94% LOSS

ONCORMED Closed on 9/28/98 at $1.86 for a 35% LOSS

CELLPRO Closed on 9/29/98 at 6¢ for a 98% LOSS

GOLDEN EAGLE GROUP Closed on 9/30/98 at $3.78 for a 68% GAIN

TSENG LABS Closed on 10/30/98 at $7.00 for a 133% GAIN

DATARACE Closed on 11/4/98 at $4.31 for a 115% GAIN

AG ASSOCIATES Closed on 11/25/98 at $4.18 for a 109% GAIN

SWISSRAY INTL Closed on 11/25/98 at $0.44 for a 95% LOSS

PERLE SYSTEMS. Closed on 12/7/98 at $2.71 for a 80% GAIN

FUSION MEDICAL. Closed on 12/7/98 at $11.00 for a 128% GAIN

Some of our other recommendations, featured in The Newsletter, include:

• A China play capitalizing of the country's liquid petroleum gas market.
  EXCHANGE: OTCBB RECOMMENDED PRICE: 29¢ TARGET: 75¢ - $1.00

• A provider of in-home patient care.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $4.50 TARGET: $6.50 - $7.00

• An energy company that could be sitting on top of an "Elephant Field" in Columbia.
  EXCHANGE: AMEX RECOMMENDED PRICE: $4.75 TARGET: $10

• A gold producer claiming to have 1.8 million ounces of proven reserves in Chile.
  EXCHANGE: NYSE RECOMMENDED PRICE: $4.50 TARGET: $7.00 - $8.00

• An energy company that has increased revenues by 60%.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.81 TARGET: $4.25 - $5.50

• A biotech company that has grown despite adversity.
  EXCHANGE: OTCBB RECOMMENDED PRICE: 88¢ TARGET: $1.75 - $2.25

• A high-tech company poised for a turnaround.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $3.00 TARGET: $5.00 - $7.00

• A manufacturer of plastics products and storage tanks that has had favorable insider activity, and pays a dividend.
  EXCHANGE: AMEX RECOMMENDED PRICE: $1.50 TARGET: $2.25 - $2.75

• A 185 store franchised restaurant chain featuring low-cost food items.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: 72¢ TARGET: $1.25 - $1.50

• A U.S. gold play that will need a little investor patience.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: 93¢ TARGET: $1.75 - $2.25

• A developer and marketer of environmental sensor equipment.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: 31¢ TARGET: 75¢ - $1.00

• A Canadian diamond mining company that is in a joint venture with De Beers.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $3.18 TARGET: $5.50 - $6.50

• The leading provider of alternate site infusion therapy in the U.S.
  EXCHANGE: NYSE RECOMMENDED PRICE: $3.18 TARGET: $8.50 - $11.00

• A developmental-stage biotech with some very promising oral tolerance drugs.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.75 TARGET: $7.50 - $9.00

• A medical equipment maker recently included in The Wired Interactice.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $4.81 TARGET: $9.00 - $11.00

• A leading provider of blood products and services.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: 75¢ TARGET: $1.60 - $2.00

• A software provider with a customer base of 2000 blue chip clients.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $3.12 TARGET: $8.50 - $10.00

• A biotech that is in late-stage trials on a treatment for lymph cancer.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.38 TARGET: $6.50 - $7.00

• The largest HMO in New York State's Hudson River Valley.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.00 TARGET: $5.50 - $6.50

• A biotech that markets diagnostic imaging agents for the colorectal and ovarian cancers.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.12 TARGET: $7.00 - $7.50

• A software developer of products that allows PC users to communicate across diverse networking environments.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.50 TARGET: $6.00 - $7.00

• A hitech whose broad product line, based on ATM technology, addresses some of the fastest growing networking areas.
  EXCHANGE: NYSE RECOMMENDED PRICE: $4.12 TARGET: $8.50 - $10.00

• A helthcare management company that owns or manages five HMO's.
  EXCHANGE: NYSE RECOMMENDED PRICE: $2.62 TARGET: $5.75 - $6.50

• A hi-tech that makes and distributes digital equipment and software used in television production.
  EXCHANGE: NYSE RECOMMENDED PRICE: $3.88 TARGET: $8.50 - $9.50

• A company that has bugs soak up the sulphur in crude oil and petroleum products.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.38 TARGET: $5.00 - $6.50

• A wireless telecomm that portends to be a wild ride.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $1.31 TARGET: $2.75 - $3.00

• A video rental company that looks as if it could be making a comeback.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.75 TARGET: $4.75 - $5.00

• A gaming company that looks as if it could again become the high flier it once was.
  EXCHANGE: NASDAQ RECOMMENDED PRICE: $4.38 TARGET: $9.00 - $10.00

• A leading provider of hitech solutions designed to improve productivity in the workplace.
  EXCHANGE: OTCBB RECOMMENDED PRICE: $2.00 TARGET: $4.00 - $5.00

• A Canadian gold producer that not only is expanding its operations, but is still making money.
  EXCHANGE: AMEX RECOMMENDED PRICE: $2.75 TARGET: $5.50 - $7.00

The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.